Is a complete LUCD research report available?

No complete published report is available for Lucid Diagnostics Inc. (LUCD) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Lucid Diagnostics Inc. (LUCD)

NASDAQ: LUCD · USD

$0.91

-0.04 (-4.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first LUCD analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	173.1M
Revenue (ttm)	5.1M
Net income (ttm)	-58.2M
EPS (ttm)	-$0.49
Shares out	190.8M
Volume	1,605,327
Beta	1.07
Price target	$3.95	+335.2%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 5.1M
Net income (ttm): -58.2M
EPS (ttm): -$0.49
Market cap: 173.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All LUCD indicators

Market & fundamental data

Available fields

207

Groups with data

Currency

USD

Showing 207 of 207 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001799011
Company name	Lucid Diagnostics Inc.
Country	United States
Country code	US
Cusip	54948X109
Employees	82
Employees Change	10%
Employees Change Percent	13.89
Enterprise value	$170.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Industry PE	40.31
Industry PE Fwd	18.65
IPO Date	2021-10-14
Isin	US54948X1090
Last refreshed	2026-07-25
Market cap	$173.1M
Market cap category	Micro-Cap
Price	$0.91
Price currency	USD
Rev Per Employee	62,609.76x
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.59
Sic	3841
Symbol	LUCD
Website	https://www.luciddx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-33.6%
EV Sales Forward	17.26x
EV/Sales	33.23x
FCF yield	-26.82%
P/B ratio	43.29x
P/S ratio	33.73x
PS Forward	17.52x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-959.64%
EBITDA Margin	-942.64%
Gross margin	-31.36%
Gross Profit	$-1.6M
Net Income	$-58.2M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-876.72%
Profit Per Employee	$-709,500
ROA	-92.09
Roa5y	-84.14
ROCE	-1,049.4
Roe5y	-891.1
ROIC	-101.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-18.98%
Cagr3y	-12.61%
EPS Growth Quarters	4
EPS Growth Years	3
Revenue Growth	23.03x
Revenue Growth Q	51.69x
Revenue Growth Quarters	4x
Revenue Growth Years	3x
Revenue Growth3 Y	100.81x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.15
Assets	$34.1M
Cash	$29.4M
Current Assets	$31.4M
Current Liabilities	$29.4M
Debt	$26.8M
Debt Equity	$6.7
Equity	$4M
Interest Coverage	-2,593.1
Liabilities	$30.1M
Long Term Assets	$2.7M
Long Term Liabilities	$695,000
Net Cash	$2.6M
Net Cash By Market Cap	$1.48
Net Debt Equity	$-0.64
Tangible Book Value	$-6.3M
Tangible Book Value Per Share	$-0.04
WACC	8.77

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.07
Inventory Turnover	14.15
Net Working Capital	$-1.3M
Quick ratio	1.02
Working Capital	$2M
Working Capital Turnover	$-1.46

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-112.13%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-18.96%
200-day SMA	1.15
3Y total return	-33.26%
50-day SMA	1.01
50-day SMA vs 200-day SMA	50under200
All Time High	13.52
All Time High Change	-93.29%
All Time High Date	2021-10-14
All Time Low	0.63
All Time Low Change	44.04%
All Time Low Date	2024-04-25
ATR	0.07
Beta	1.07
Beta1y	0.64
Beta2y	0.36
Ch YTD	-16.73
High	0.95
High52	1.63
High52 Date	2026-01-21
High52ch	-44.28%
Low	0.91
Low52	0.9
Low52 Date	2026-05-20
Low52ch	0.84%
Ma50ch	-10.32%
Premarket Change Percent	0.48
Premarket Price	$0.95
Premarket Volume	259
Price vs 200-day SMA	-20.73%
RSI	39.77
RSI Monthly	37.98
RSI Weekly	38.97
Sharpe ratio	-0.06x
Sortino ratio	0
Total Return	-112.13%
Tr YTD	-16.73
Tr1m	-11.88%
Tr1w	-4.48%
Tr3m	-16.73%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	2
Analyst Price Target Top	$3
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.05
Earnings Revenue Estimate	1,445,920x
Earnings Revenue Estimate Growth	24.33x
Operating Income	$-49.3M
Operating margin	-959.6
Price target	$3.95
Price Target Change	$335
Price Target Change Top	$231

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	140,584,149%
Float Percent	73.69%
Shares Insiders	5.96%
Shares Institutions	19.43%
Shares Out	190,771,543
Shares Qo Q	6.62%
Shares Yo Y	112.13%
Short Float	6.7%
Short Ratio	5.6
Short Shares	4.94

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-51.3M
Average Volume	1,986,381.25x
Bv Per Share	-0.04
CAPEX	$-319,000
Ch1m	-11.88
Ch1w	-4.48
Ch1y	-18.96
Ch3m	-16.73
Ch3y	-33.26
Ch6m	-24.99
Change	-4.01%
Change From Open	-4.46
Close	0.95
Days Gap	0.48
Depreciation Amortization	873,000
Dollar Volume	1,456,994.8
Earnings Date	2026-08-12
Earnings Time	bmo
EBIT	$-49.3M
EBITDA	$-48.4M
EPS	$-0.49
F Score	4
FCF	$-46.4M
FCF EV Yield	-27.23x
FCF Per Share	$-0.24
Financing CF	49,078,000
Fiscal Year End	December
Founded	2,018
Investing CF	-319,000
Ipr	-93.52
Iprfo	-92.88
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-14
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-25
Ma150	1.15
Ma150ch	-21.08%
Ma20	1.01
Ma20ch	-10.23%
Net CF	2,638,000
Next Earnings Date	2026-08-12
Open	0.95
Optionable	No
Position In Range	5.57
Post Close	0.91
Postmarket Change Percent	1.09
Postmarket Price	$0.92
Ppne	2,498,000
Pre Close	0.95
Price Date	2026-07-24
Relative Volume	0.81x
Revenue	5,134,000x
SBC By Revenue	94.9x
Share Based Comp	4,872,000
Tr6m	-24.99%
Us State	New York
Volume	1,605,327
Z Score	-13.96

Lucid Diagnostics Inc. (LUCD)

Coverage state: Market snapshot only — no published research

Generate the first LUCD analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · LUCD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LUCD indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on LUCD

Frequently asked questions